Literature DB >> 22822081

Negative regulators of integrin activity.

Jeroen Pouwels1, Jonna Nevo, Teijo Pellinen, Jari Ylänne, Johanna Ivaska.   

Abstract

Integrins are heterodimeric transmembrane adhesion receptors composed of α- and β-subunits. They are ubiquitously expressed and have key roles in a number of important biological processes, such as development, maintenance of tissue homeostasis and immunological responses. The activity of integrins, which indicates their affinity towards their ligands, is tightly regulated such that signals inside the cell cruicially regulate the switching between active and inactive states. An impaired ability to activate integrins is associated with many human diseases, including bleeding disorders and immune deficiencies, whereas inappropriate integrin activation has been linked to inflammatory disorders and cancer. In recent years, the molecular details of integrin 'inside-out' activation have been actively investigated. Binding of cytoplasmic proteins, such as talins and kindlins, to the cytoplasmic tail of β-integrins is widely accepted as being the crucial step in integrin activation. By contrast, much less is known with regard to the counteracting mechanism involved in switching integrins into an inactive conformation. In this Commentary, we aim to discuss the known mechanisms of integrin inactivation and the molecules involved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22822081     DOI: 10.1242/jcs.093641

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  21 in total

Review 1.  Integrin inactivators: balancing cellular functions in vitro and in vivo.

Authors:  Daniel Bouvard; Jeroen Pouwels; Nicola De Franceschi; Johanna Ivaska
Journal:  Nat Rev Mol Cell Biol       Date:  2013-05-30       Impact factor: 94.444

Review 2.  Talin and Kindlin as Integrin-Activating Proteins: Focus on the Heart.

Authors:  Chao Chen; Ana Maria Manso; Robert S Ross
Journal:  Pediatr Cardiol       Date:  2019-07-31       Impact factor: 1.655

Review 3.  Talin and kindlin: the one-two punch in integrin activation.

Authors:  Feng Ye; Adam K Snider; Mark H Ginsberg
Journal:  Front Med       Date:  2014-01-29       Impact factor: 4.592

Review 4.  Leukocyte arrest: Biomechanics and molecular mechanisms of β2 integrin activation.

Authors:  Zhichao Fan; Klaus Ley
Journal:  Biorheology       Date:  2015       Impact factor: 1.875

Review 5.  Chapter 22: Structural and signaling functions of integrins.

Authors:  Yasmin A Kadry; David A Calderwood
Journal:  Biochim Biophys Acta Biomembr       Date:  2020-01-25       Impact factor: 3.747

6.  Phosphorylation of the α-chain in the integrin LFA-1 enables β2-chain phosphorylation and α-actinin binding required for cell adhesion.

Authors:  Farhana Jahan; Sudarrshan Madhavan; Taisia Rolova; Larisa Viazmina; Mikaela Grönholm; Carl G Gahmberg
Journal:  J Biol Chem       Date:  2018-06-14       Impact factor: 5.157

7.  SHARPIN controls the development of regulatory T cells.

Authors:  Vanessa Redecke; Vandana Chaturvedi; Jeeba Kuriakose; Hans Häcker
Journal:  Immunology       Date:  2016-04-12       Impact factor: 7.397

8.  Insulin-like growth factor binding protein-3 inhibits cell adhesion via suppression of integrin β4 expression.

Authors:  Hyo-Jong Lee; Ji-Sun Lee; Su Jung Hwang; Ho-Young Lee
Journal:  Oncotarget       Date:  2015-06-20

Review 9.  Talins and kindlins: partners in integrin-mediated adhesion.

Authors:  David A Calderwood; Iain D Campbell; David R Critchley
Journal:  Nat Rev Mol Cell Biol       Date:  2013-07-17       Impact factor: 94.444

10.  Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors.

Authors:  Florence Schaffner; Anne Marie Ray; Monique Dontenwill
Journal:  Cancers (Basel)       Date:  2013-01-15       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.